Phyto Chem (India) Ltd
Incorporated in 1989, Phyto Chem Ltd is in the manufacturing of pesticide formulations and real estate activities[1]
- Market Cap ₹ 12.2 Cr.
- Current Price ₹ 28.4
- High / Low ₹ 39.9 / 24.5
- Stock P/E
- Book Value ₹ 12.5
- Dividend Yield 0.00 %
- ROCE 3.27 %
- ROE -14.6 %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -20.5% over past five years.
- Company has a low return on equity of -16.0% over last 3 years.
- Earnings include an other income of Rs.3.16 Cr.
- Company has high debtors of 369 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29.29 | 40.92 | 21.77 | 44.45 | 58.90 | 59.11 | 44.22 | 44.49 | 23.12 | 26.76 | 14.75 | 14.08 | 10.97 | |
| 26.32 | 38.27 | 20.24 | 41.58 | 56.75 | 56.68 | 42.30 | 42.28 | 21.70 | 24.16 | 18.02 | 15.42 | 12.81 | |
| Operating Profit | 2.97 | 2.65 | 1.53 | 2.87 | 2.15 | 2.43 | 1.92 | 2.21 | 1.42 | 2.60 | -3.27 | -1.34 | -1.84 |
| OPM % | 10.14% | 6.48% | 7.03% | 6.46% | 3.65% | 4.11% | 4.34% | 4.97% | 6.14% | 9.72% | -22.17% | -9.52% | -16.77% |
| -0.06 | 0.12 | 0.68 | 0.27 | 1.55 | 0.98 | 1.38 | 0.80 | 1.29 | 0.16 | 2.32 | 2.47 | 3.16 | |
| Interest | 1.63 | 1.64 | 1.72 | 1.67 | 2.13 | 2.10 | 2.47 | 2.12 | 2.10 | 2.10 | 2.05 | 1.84 | 1.77 |
| Depreciation | 0.35 | 0.32 | 0.31 | 0.31 | 0.36 | 0.40 | 0.41 | 0.43 | 0.41 | 0.40 | 0.34 | 0.34 | 0.34 |
| Profit before tax | 0.93 | 0.81 | 0.18 | 1.16 | 1.21 | 0.91 | 0.42 | 0.46 | 0.20 | 0.26 | -3.34 | -1.05 | -0.79 |
| Tax % | 34.41% | 34.57% | 38.89% | 26.72% | 23.97% | 19.78% | -4.76% | -6.52% | -15.00% | 15.38% | -0.30% | -5.71% | |
| 0.61 | 0.54 | 0.12 | 0.85 | 0.92 | 0.73 | 0.45 | 0.49 | 0.23 | 0.22 | -3.33 | -0.99 | -0.68 | |
| EPS in Rs | 1.42 | 1.26 | 0.28 | 1.98 | 2.14 | 1.70 | 1.05 | 1.14 | 0.53 | 0.51 | -7.74 | -2.30 | -1.59 |
| Dividend Payout % | 70.49% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -10% |
| 5 Years: | -20% |
| 3 Years: | -15% |
| TTM: | -31% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 76% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | 4% |
| 3 Years: | -8% |
| 1 Year: | -11% |
| Return on Equity | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -8% |
| 3 Years: | -16% |
| Last Year: | -15% |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 |
| Reserves | 3.12 | 3.48 | 3.60 | 4.00 | 4.52 | 5.12 | 5.55 | 5.88 | 6.15 | 6.31 | 3.06 | 2.09 | 1.06 |
| 14.22 | 16.00 | 16.04 | 18.46 | 18.55 | 22.08 | 22.98 | 21.37 | 21.23 | 19.47 | 18.19 | 15.77 | 14.78 | |
| 10.53 | 11.92 | 5.63 | 15.24 | 30.31 | 41.46 | 34.87 | 13.91 | 6.78 | 9.94 | 6.16 | 5.72 | 4.91 | |
| Total Liabilities | 32.17 | 35.70 | 29.57 | 42.00 | 57.68 | 72.96 | 67.70 | 45.46 | 38.46 | 40.02 | 31.71 | 27.88 | 25.05 |
| 4.21 | 3.68 | 3.50 | 3.25 | 4.10 | 4.18 | 4.67 | 3.43 | 3.13 | 2.75 | 2.74 | 2.39 | 2.23 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 | 0.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.32 | 0.32 | 0.32 | 0.24 | 0.25 | 0.12 | 0.11 | 0.16 | 0.17 | 0.07 | 0.08 | 0.05 | 0.07 |
| 27.64 | 31.70 | 25.75 | 38.51 | 53.24 | 68.21 | 62.92 | 41.87 | 35.16 | 37.20 | 28.89 | 25.44 | 22.75 | |
| Total Assets | 32.17 | 35.70 | 29.57 | 42.00 | 57.68 | 72.96 | 67.70 | 45.46 | 38.46 | 40.02 | 31.71 | 27.88 | 25.05 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.71 | -2.13 | -0.34 | 1.53 | 0.76 | 1.95 | 1.49 | -0.71 | 3.41 | 1.42 | 3.41 | 1.77 | |
| -0.71 | 0.32 | 0.60 | 0.16 | 0.24 | 0.26 | -0.39 | 1.06 | 0.05 | 0.21 | -0.05 | 1.02 | |
| 2.43 | 1.79 | -0.48 | -1.76 | -1.02 | -2.19 | -1.10 | -0.40 | -3.45 | -1.70 | -3.26 | -2.91 | |
| Net Cash Flow | 0.01 | -0.02 | -0.23 | -0.06 | -0.01 | 0.02 | -0.01 | -0.05 | 0.01 | -0.07 | 0.10 | -0.12 |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 209.73 | 155.83 | 247.97 | 212.84 | 234.37 | 306.89 | 360.30 | 182.87 | 317.01 | 275.66 | 388.26 | 369.41 |
| Inventory Days | 167.93 | 159.73 | 260.64 | 133.35 | 115.59 | 128.58 | 182.77 | 172.49 | 342.41 | 314.83 | 373.42 | 338.21 |
| Days Payable | 99.24 | 113.43 | 86.08 | 135.72 | 176.25 | 283.01 | 338.07 | 110.32 | 41.10 | 122.87 | 91.09 | 91.75 |
| Cash Conversion Cycle | 278.42 | 202.12 | 422.53 | 210.47 | 173.71 | 152.46 | 205.00 | 245.04 | 618.32 | 467.62 | 670.59 | 615.87 |
| Working Capital Days | 59.32 | 48.26 | 103.95 | 53.62 | 43.75 | 45.14 | 69.58 | 85.08 | 155.35 | 150.45 | 161.34 | 129.88 |
| ROCE % | 13.06% | 12.02% | 7.75% | 11.16% | 12.34% | 10.16% | 8.98% | 6.96% | 7.28% | 7.55% | -4.93% | 3.27% |
Documents
Announcements
- Results-Financial Results For SEP 30, 2025 (Submission Of Unaudited Financial Results Of The Company For The Second Quarter And Half-Year Ended 30Th September 2025 - In Compliance Of Regulation 33 Of The SEBI (LODR) Regulations, 2015-Regarding 14 Nov
-
Board Meeting Outcome for Outcome Of Board Meeting- In Compliance Of Regulation 30(6) Of The SEBI (LODR) Regulations, 2015 - Regarding
14 Nov - Board approved unaudited financial results for quarter and half-year ended 30 Sep 2025.
-
Board Meeting Intimation for Intimation Of Board Meeting To Consider Unaudited Financial Results For The Second Quarter And Half Year Ended 30Th September 2025 Under Regulation 29 Of SEBI (LODR) Regulations, 2015 - Regarding.
6 Nov - Board meeting on 14-Nov-2025 04:00 P.M. to consider Q2/H1 unaudited results; trading window closed from 01-10-2025.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
10 Oct - The securities received for dematerialisation have been mutilated and cancelled after due verification and the name of the respective depository has been updated in the …
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 30 Sep
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
PCL operates in the Agrochemicals sector and is engaged in the manufacturing and marketing of Pesticides for the agriculture sector. Its products are marketed under proprietary brands through a dealer and distributor network in Telangana, Andhra Pradesh, Maharashtra, and Karnataka.
The company's operations are spread across two segments:
a) Pesticides Formulations
b) Real Estate Activities